Insulin lispro

CAS : 133107-64-9

Ref. 3D-IFA10764

Informations sur le produit

• Nom: Insulin lispro
• Synonymes: (Lys(B28),Pro(B29))-Humaninsulin, 28B-L-Lysine-29B-L-Proline-Insulin(Human, 28B-L-Lysine-29B-L-Prolineinsulin(Human), 8A-L-Threonine-10A-L-Isoleucine-28B-L-Lysine-29B-L-Proline-30B-Insulin(Ox, Insulinlispro
• CAS: 133107-64-9

Description

Insulin lispro is a form of insulin that is used to treat diabetes. Insulin lispro contains a recombinant DNA molecule with a sequence identical to human insulin, and contains the same amino acid sequence as human insulin. It has two-way crossover, long-term efficacy, and low magnesium salt. The two-way crossover study was conducted on patients with diabetic neuropathy and showed an improved efficacy of oral hypoglycemic agents. The long-term efficacy of insulin lispro was demonstrated in a study that lasted for one year. Insulin lispro has been shown to be effective in the treatment of metabolic disorders such as diabetes and autoimmune diseases such as type 1 diabetes. Insulin lispro has been shown to have pharmacokinetic properties similar to those of human serum.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 5,814 g/mol
• Formule: C₂₅₇H₃₈₉N₆₅O₇₇S₆
• Degré de pureté: Min. 95%